Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : HemaCare Corporation (HEMA), profitable -- Ignore unavailable to you. Want to Upgrade?

To: MeDroogies who wrote (63)	6/3/2001 11:49:29 AM
From: NCC-1911 D	Read Replies (4) \| Respond to of 70

HEMA is moving up on nice volume--the market cap is still below revenues, and the company is buying back their own stock----there could be a MAJOR BLOOD SHORTAGE looming, because the FDA, fearful of mad-cow disease, may ban donors who have lived in Europe from donating blood. Hemacare, could help to alleviate the potential shortage. I reviewed HEMA's balance sheet etc---it seems to me that if HEMA stock trades above $3-4, it would meet NASDAQ requirements--am I wrong?? If HEMA were to go NASDAQ, it could have a significant move up IMO.